Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype which lacks the estrogen receptor (ER) and progesterone receptor (PR) expression and also lacks overexpression of the human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to breast carcinoma.